$DW8 Bull flag, volume spike. Next leg uptoRSI bottomed on 4H, Bull flag formed, Volume spike leads me to believe we're going to break out and go to Fib 1.618 extension @ ~0.195 as first target.
Only started uptrend 11 Feb so I think it's still got some juice left in the tank to go further.
DYOR and GLTAH!
TA
Last call to get on board to 70kBTC benefits from a lot of supply support lines on multiple levels that have prevented it from going any lower since it’s ATH of 61k. There is no directional consensus on the timescales that indicates an end to the bill run. Although it seems hesitant to go any higher it really is just in “transit” to 70k.
Do your own research, this is not financial advice.
BCLI Technical Analysis 🧙Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
EPZM Technical Analysis 🧙Epizyme Inc is a clinical-stage biopharmaceutical company that is committed to rewriting treatment for cancer and other serious diseases through discovering, developing and commercializing novel epigenetic medicines. Its product candidates include tazemetostat, an inhibitor of the EZH2, which is in Phase II clinical trial for patients with relapsed or refractory non-hodgkin lymphoma (NHL), Phase II clinical trial for relapsed or refractory patients with mesothelioma, Phase I dose-escalation and expansion study for children with INI1-negative solid tumors. The company is also developing additional programs, such as pinometostat, an intravenously administered small molecule inhibitor of DOT1L for the treatment of acute leukemias and PRMT5 inhibitor.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
PSXP Technical Analysis 🧙Phillips 66 Partners is a master limited partnership that provides fee-based transportation, processing, storage, and fractionation services primarily to Phillips 66, which owns a 74% limited partner interest. Phillips 66 Partners’ primary revenue sources are long-term, fee-based contracts to handle crude, natural gas liquids, and refined products. Phillips 66 manages and operates Phillips 66 Partners as its noneconomic general partner. Phillips 66’s general partner economic interest and incentive distribution rights were eliminated in August 2019.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
FGEN Technical Analysis 🧙FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
APT Technical Analysis 🧙Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply, Disposable Protective Apparel and Infection Control. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
AFIB Technical Analysis 🧙Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, ablation catheters, mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. Its operates in United States and Europe with majority of the revenue generating from Europe.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
ADVM Technical Analysis 🧙Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durability with treatment response, reduce the treatment burden of frequent anti-vascular endothelial growth factor (anti-VEGF) injections, and improve real-world vision outcomes for patients.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
BNB - Might run up to ATH soon. Here's a quick look at BNB 4 hr chart. Not long before we see a bigger move - Probably to the upside. As we can observe, the price broke out from the big sym. triangle and is now forming a bigger bull flag. If it breaks to the upside, it is then very likely that we see a run up to new ATH - 450$ next ATH
The idea is: Buy the breakout from the level shown in the chart. Take profits at the level shown in the chart.
Targets:
1. 308$
2. 347$
3. 450$
Follow me for daily trading setups - Telegram group will be available soon
BTC dictates the market. If BTC falls, then Alts will fall as well. BTC needs to get stable before alts can run. Trade safe!
EPZM Technical Analysis 🧙Epizyme Inc is a clinical-stage biopharmaceutical company that is committed to rewriting treatment for cancer and other serious diseases through discovering, developing and commercializing novel epigenetic medicines. Its product candidates include tazemetostat, an inhibitor of the EZH2, which is in Phase II clinical trial for patients with relapsed or refractory non-hodgkin lymphoma (NHL), Phase II clinical trial for relapsed or refractory patients with mesothelioma, Phase I dose-escalation and expansion study for children with INI1-negative solid tumors. The company is also developing additional programs, such as pinometostat, an intravenously administered small molecule inhibitor of DOT1L for the treatment of acute leukemias and PRMT5 inhibitor.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
purple star?could be a purple star rocket ship moment, or I could be wrong. Just doing TA on the 4hr, and that's what I see. But for XTZ to fail I assume BTC would lead the way; how will we pay off our countries debt if not through cryptocurrencies. Not Financial Advice but even if you have 0 debt in USA your 60K+ in debt soo lets get on with it and make paper obsolete, just pay us in crypto so it saves us the hassle of going to the bank.
strong resistance at $5.5...
if BTC is going to 65K then XTZ can break $5.5
AHPI Technical Analysis 🧙Allied Healthcare Products Inc is a US-based company. It mainly manufactures a variety of respiratory products used in the healthcare industry in a wide range of hospital and alternate site settings, including sub-acute care facilities, home health care, and emergency medical care. The product line of the company includes respiratory anesthesia products, home respiratory care products, medical gas system construction products, medical gas system regulation devices, disposable oxygen, and specialty gas cylinders, portable suction equipment, trauma, and patient handling products, respiratory products, and others. The company markets its products under various brand names Timeter, Carbolime, Litholyme, Schuco, Chemetron, Oxequip, Lif-O-Gen, Gomco, and others.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
ASMB Technical Analysis 🧙Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
BTC confirms Symmetrical Triangle, Fundamentals point LowerWe now have multiple touches on both the descending upper and ascending lower trendlines showing BTCUSD in a clear Symmetrical Triangle.
This is not rocket science this is basic triangle patterns, trendlines, and Technical Analysis.
These triangles more often than not respect the fundamentals and if it does so here then we are looking to break down to lower lows.
This however comes on the heels of big news coming out of the US and the Senate passing the 1.9 Trillion dollar bill including the "Biden Bucks"
to every American. This translates into potentially billions in retail potentially entering the market in the next few weeks as the checks start rolling out.
We expect more downside short term. A BTC close above $51.1k would cause us to throw that idea out and look for bullish short-term sentiment...
Right now however we are not bullish... We are still short and holding, we will see what happens as we move further down.
$38 to 39.7k is a huge liquidity zone in our opinions and we have staggered in a lot of spot buys down there.
Remember the 21 week EMA is the line in the sand and that is still down around $31k, so stop FUDing we are still in a Bull Market!
Big picture analysis on BITCOIN! (Over 100k)What is up my Tradingview family! as you know I have been posting bearish charts on Bitcoin in the short term but today I would like to share with you what is happening in the BIG PICTURE.
When I saw a short term correction coming I took profits and reduced risk HOWEVER I never EVER sell 100% of my position on Bitcoin because this is simply stupid considering the big picture trend.. Its better to sell 20% - 30%.
BTC
ETH
I am now in a very good place with a good chunk in the markets and USDT that I have been steadily deploying (AVG DOWN) back into the dip. This is compounding my portfolio!
In the short term a correction could be over OR it could still see one more sharp leg down. (this is why your AVG back into the market) when you sell into FOMO its very nice because the worst case scenario you buy back near or below the price you sold - the best case scenario you buy everything at MASSIVE DISCOUNTS.
In the big picture I expect Bitcoin to reach $90,000 - $100,000 then proceed to FOMO to $230,000 and potentially $250,000 per coin.
This cycle is a repeat of the 2013 2014 cycle (in fractal nature) but can easily FOMO even higher than that one did.
Stay profitable!
looks like supportgreat job, nice shake out. Now i remember missing the OMG train a few years ago... lets see what it can do in 2021!